First Trial Shows Ebola Vaccine Safe, Provokes Immune Response

London (PNA/PTI) — The first human trial of a candidate Ebola vaccine suggests it is safe to use and generates an immune response, Oxford scientists said.

“The vaccine was well tolerated. Its safety profile is pretty much as we had hoped,” said Professor Adrian Hill of the Jenner Institute at Oxford University, who led the trial. (PNA/PTI) FFC/RSM